000 01448 a2200409 4500
005 20250512232924.0
264 0 _c19811029
008 198110s 0 0 eng d
022 _a0091-6749
024 7 _a10.1016/0091-6749(81)90181-0
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSheffer, A L
245 0 0 _aClinical and biochemical effects of stanozolol therapy for hereditary angioedema.
_h[electronic resource]
260 _bThe Journal of allergy and clinical immunology
_cSep 1981
300 _a181-7 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aAndrogens
_xpharmacology
650 0 4 _aAngioedema
_xdrug therapy
650 0 4 _aComplement C1 Inactivator Proteins
650 0 4 _aCreatine Kinase
_xpharmacology
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMenstruation Disturbances
_xetiology
650 0 4 _aMiddle Aged
650 0 4 _aOxymetholone
_xtherapeutic use
650 0 4 _aPregnancy
650 0 4 _aStanozolol
_xadverse effects
650 0 4 _aThyroxine-Binding Proteins
_xblood
700 1 _aFearon, D T
700 1 _aAusten, K F
773 0 _tThe Journal of allergy and clinical immunology
_gvol. 68
_gno. 3
_gp. 181-7
856 4 0 _uhttps://doi.org/10.1016/0091-6749(81)90181-0
_zAvailable from publisher's website
999 _c6790350
_d6790350